Cargando…
Physiology and Emerging Biochemistry of the Glucagon-Like Peptide-1 Receptor
The glucagon-like peptide-1 (GLP-1) receptor is one of the best validated therapeutic targets for the treatment of type 2 diabetes mellitus (T2DM). Over several years, the accumulation of basic, translational, and clinical research helped define the physiologic roles of GLP-1 and its receptor in reg...
Autores principales: | Willard, Francis S., Sloop, Kyle W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359799/ https://www.ncbi.nlm.nih.gov/pubmed/22666230 http://dx.doi.org/10.1155/2012/470851 |
Ejemplares similares
-
Small Molecule Drug Discovery at the Glucagon-Like Peptide-1 Receptor
por: Willard, Francis S., et al.
Publicado: (2012) -
Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles
por: Bueno, Ana B., et al.
Publicado: (2016) -
Glucagon-Like Peptide-1 Receptor Ligand Interactions: Structural Cross Talk between Ligands and the Extracellular Domain
por: West, Graham M., et al.
Publicado: (2014) -
Equine glucagon-like peptide-1 receptor physiology
por: Kheder, Murad H., et al.
Publicado: (2018) -
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets
por: Sloop, Kyle W., et al.
Publicado: (2010)